ACÉTYLSALICYLATE DE LYSINE À ADMINISTRATION INTRAVITRÉENNE UTILISÉ COMME TRAITEMENT DE LA RÉTINOPATHIE DIABÉTIQUE
- 专利权人:
- Fundación Para El Fomento De La Investigación Sanitaria Y Biomédica De La Comunitat Valenciana;Universidad de Castilla La Mancha
- 发明人:
- 申请号：
- EP16799403.7
- 公开号：
- EP3305300A1
- 申请日:
- 2016.05.26
- 申请国别(地区):
- EP
- 年份:
- 2018
- 代理人:
- 摘要：
- The invention relates to the use of a composition comprising lysine acetylsalicylate for the production of a drug in a form suitable for intravitreal administration, for the treatment of diabetic retinopathy.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- ACÉTYLSALICYLATE DE LYSINE À ADMINISTRATION INTRAVITRÉENNE UTILISÉ COMME TRAITEMENT DE LA RÉTINOPATHIE DIABÉTIQUE
- Food for the prevention or treatment of diabetic retinopathy and food for the prevention or treatment of diabetic retinopathy, food for improving various signs of diabetic retinopathy, food for the purpose of improving various signs of diabetic retinopathy, and diabetic retinopathy Method for determining the timing of administration of a preventive or ameliorating agent
- Intravitreal Lysine Acetylsalicylate As Treatment For Diabetic Retinopathy
- Methods for the treatment of diabetic retinopathy and other ophthalmic diseases
- Methods for the treatment of diabetic retinopathy and other ophthalmic diseases
